78 research outputs found
COMPLEX ESTIMATION OF BRONCHOPULMONARY SYSTEM IN PATIENTS WITH HODGKINS LYMPHOMA
One of the important problems with patients with Hodgkin's lymphoma is lung injury, caused both by a tumor effect and the influence of chemoradiotherapy. Before the treatment an obstructive lung function pattern connected with tumor substrate has been revealed in 38% of cases. After chemoradiotherapy the restrictive lung pattern was shown in 14% of the patients and mixed lung pattern was seen in 12% of the cases, which were caused by the development of pneumosclerosis and emphysema
Gradients of Taxonomic Diversity among Local Floras in the Russian Arctic
Latitudinal and longitudinal changes in taxonomic variables were analyzed in 319 local floras in the Russian Arctic. Within the studied segment of latitudinal gradient, most changes can be described in terms of linear regression with negative coefficients (a number of species, genera and families), or positive coefficients (a proportion of the leading families and genera). However, the mean number of species in a family or genus almost does not change with increasing latitude, although it slightly increases as one moves eastward. The proportion of monocots does not correlate with latitude, but slightly decreases as one moves eastward. Proportions of various families change asynchronously. Although correlation with longitude was less pronounced, mean species richness was specific to many subprovinces, even within a certain subzone. These differences reflect both the diversity of landscapes and the history of flora formation.
Keywords: the Arctic, local floras, latitudinal and longitudinal gradient, floristic subprovince
Cardiovascular system state changes in non-Hodgkinβs lymphoma patients during chemotherapy
Chemotherapy is one of reliable and proven methods of malignant tumor and blood diseases treatment but however the drug side effects (particularly cardiotoxicity) occur. More often cardiovascular complications connect with anthracyclines and related drugs (doxorubicin, daunorubicyn, epirubicyn, idarubicyn, mitoxantron) which usually used at medical scheme because of wide spectrum of action and high effectiveness prescription. Risk of cardiotoxicity formation and existing diseases progression increases according to drug dose, patientβs age, cardiovascular risk factors presence and cardiovascular diseases history. Material and methods. 88 patients with established non-Hodgkinβs lymphoma diagnosis were examined in order to assess cardiovascular system state and pathology nature β 33 patients before chemotherapy and 55 patients in the long-term follow-up period (one year after the start of chemotherapy). Results.Β It was found that antitumor drugs induced cardiotoxicity may manifest at the beginning of chemotherapy as well as following up period. The cardiac cameras dilation associated with the increase of NTproBNP serum content (N-terminal fragment of natriuretic peptide type B precursor) β the main biomarker of myocardial dysfunction has been revealed by instrumental research
INFLUENCE OF TRANEXAMIC ACID ON HEMORRHAGE AT THE REVISION HIP REPLACEMENT SURGERY
The article describes the results of investigation of the influence of tranexamic acid, on hemostasis system, at the revision hip replacement surgery. Correlation of changes in hemostasis system, and hemorrhage in intra-and postoperative periods, frequency of hemotransfusion, at the stages of the operation and in postoperative period, were evaluated. Use of tranexamic acid, at the revision hip replacement surgeries reduces perioperative hemorrhage
Π‘ΠΠ£Π§ΠΠ ΠΠΠ€Π€Π£ΠΠΠΠ Π-ΠΠ Π£ΠΠΠΠΠΠΠ’ΠΠ§ΠΠΠ ΠΠΠΠ€ΠΠΠ« Π‘ Π€Π£ΠΠΠ¦ΠΠΠΠΠΠ¬ΠΠ ΠΠΠΠ§ΠΠΠ«ΠΠ ΠΠΠ’Π ΠΠΠΠ«ΠΠ ΠΠ£Π’ΠΠ¦ΠΠ―ΠΠ Π ΠΠΠΠ Π’Π 53
Background. the presence of functionally significant intron mutations in the TP53 gene was demonstratedΒ in experiments in vitro and on samples of patients with some variants of non-Hodgkinβs lymphomas. to date,Β the studies of TP53 in tumor tissue of patients with diffuse large B-cell lymphoma (dlBCl) have been focusedΒ on the mutations in 5β8 exons of the gene. For these reasons, further studies of the spectrum of changes inΒ the intron sequences of the TP53 gene and the determination of their functional effect in dlBCl are required.Description. We present two case reports that are of interest as the cases for detection of functionallyΒ significant intron TP53 mutations in dlBCl tissue, first published in the Russian scientific literature. the firstΒ clinical case of dlBCl was clinically characterized by extranodal tumor at the onset of the disease, severeΒ symptoms of tumor intoxication, high paraclinical tumor activity, and early hemoblastosis recurrence. theΒ second case of dlBCl was characterized by initially massive tumor lesion, rapidly progressive course of theΒ disease, severe symptoms of tumor intoxication, high paraclinical tumor activity and poor response to therapyΒ with subsequent generalization of lymphoma. Conclusion. Mutations in the TP53 gene are the driver of theΒ tumor process, serve not only as a marker of aggressive tumor progression, but also as an independentΒ predictor of reduced sensitivity to treatment. the presented clinical cases show that an in-depth analysis ofΒ the results of the TP53 sequencing in tumors and functional assessment of all detected changes, includingΒ changes in the introns of the gene and involving in silico analysis techniques, are necessary.Β Β ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. Π½Π°Π»ΠΈΡΠΈΠ΅ Π² Π³Π΅Π½Π΅ Π’Π 53 ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎ Π·Π½Π°ΡΠΈΠΌΡΡ
ΠΈΠ½ΡΡΠΎΠ½Π½ΡΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π±ΡΠ»ΠΎ ΠΏΡΠΎΠ΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΠΎΠ²Π°Π½ΠΎ Π² ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Ρ
in vitro ΠΈ Π½Π° Π²ΡΠ±ΠΎΡΠΊΠ°Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΠΌΠΈ Π²Π°ΡΠΈΠ°Π½ΡΠ°ΠΌΠΈ Π½Π΅Ρ
ΠΎΠ΄ΠΆΠΊΠΈΠ½ΡΠΊΠΈΡ
Π»ΠΈΠΌΡΠΎΠΌ. ΠΠΎ Π½Π°ΡΡΠΎΡΡΠ΅Π³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ ΠΏΡΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠΈ Π’Π 53 Π² ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Π΄ΠΈΡΡΡΠ·Π½ΠΎΠΉΒ Π-ΠΊΡΡΠΏΠ½ΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ Π»ΠΈΠΌΡΠΎΠΌΠΎΠΉ (ΠΠΠΊΠΊΠ») ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±ΡΠ»ΠΈ ΡΠΎΡΡΠ΅Π΄ΠΎΡΠΎΡΠ΅Π½Ρ Π½Π° ΠΏΠΎΠΈΡΠΊΠ΅ ΠΌΡΡΠ°ΡΠΈΠΉ Π² 5β8Β ΡΠΊΠ·ΠΎΠ½Π°Ρ
Π³Π΅Π½Π°. ΠΠΎ ΡΡΠΈΠΌ ΠΏΡΠΈΡΠΈΠ½Π°ΠΌ ΡΡΠ΅Π±ΡΡΡΡΡ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠΏΠ΅ΠΊΡΡΠ° ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π² ΠΈΠ½ΡΡΠΎΠ½Π½ΡΡ
Β ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ
Π³Π΅Π½Π° Π’Π 53 ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΈΡ
ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΡΠ΅ΠΊΡΠ° ΠΏΡΠΈ ΠΠΠΊΠΊΠ». ΠΠΏΠΈΡΠ°Π½ΠΈΠ΅.Β Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π΄Π²Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΡΡ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ ΠΊΠ°ΠΊ Π²ΠΏΠ΅ΡΠ²ΡΠ΅Β ΠΏΡΠ±Π»ΠΈΠΊΡΠ΅ΠΌΡΠ΅ Π² ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π½Π°ΡΡΠ½ΠΎΠΉ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ΅ ΡΠ»ΡΡΠ°ΠΈ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎ Π·Π½Π°ΡΠΈΠΌΡΡ
ΠΈΠ½ΡΡΠΎΠ½Π½ΡΡ
Β ΠΌΡΡΠ°ΡΠΈΠΉ Π’Π 53 Π² ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΠΠΊΠΊΠ». ΠΠ΅ΡΠ²ΡΠΉ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ ΠΠΠΊΠΊΠ» Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π»ΡΡΒ ΡΠΊΡΡΡΠ°Π½ΠΎΠ΄Π°Π»ΡΠ½ΡΠΌ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΠΌ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ Π² Π΄Π΅Π±ΡΡΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌΠΈ ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΠΌΠΈ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉΒ ΠΈΠ½ΡΠΎΠΊΡΠΈΠΊΠ°ΡΠΈΠΈ, Π²ΡΡΠΎΠΊΠΎΠΉ ΠΏΠ°ΡΠ°ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ, ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΡΠ°Π½Π½Π΅Π³ΠΎ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²Π° Π³Π΅ΠΌΠΎΠ±Π»Π°ΡΡΠΎΠ·Π° Ρ ΡΠΊΡΡΡΠ°Π½ΠΎΠ΄Π°Π»ΡΠ½ΡΠΌ ΠΎΡΠ°Π³ΠΎΠΌ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ Π² Π·Π°Π±Π°ΡΡΠ΅ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ, ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΠΌ ΠΊ Π»Π΅ΡΠ΅Π½ΠΈΡ. ΠΡΠΎΡΠΎΠΉΒ ΠΎΠΏΠΈΡΠ°Π½Π½ΡΠΉ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ ΠΠΠΊΠΊΠ» Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π»ΡΡ ΠΈΡΡ
ΠΎΠ΄Π½ΠΎ ΠΌΠ°ΡΡΠΈΠ²Π½ΡΠΌ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΠΌ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ,Β Π±ΡΡΡΡΠΎΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΡΡΡΠΈΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌΠΈ ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΠΌΠΈ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΠΈΠ½ΡΠΎΠΊΡΠΈΠΊΠ°ΡΠΈΠΈ,Β Π²ΡΡΠΎΠΊΠΎΠΉ ΠΏΠ°ΡΠ°ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΈ ΠΏΠ»ΠΎΡ
ΠΈΠΌ ΠΎΡΠ²Π΅ΡΠΎΠΌ Π½Π° ΡΠ΅ΡΠ°ΠΏΠΈΡ Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅ΠΉ Π³Π΅Π½Π΅ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠ΅ΠΉ Π»ΠΈΠΌΡΠΎΠΌΡ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΡΠ°ΡΠΈΠΈ Π² Π³Π΅Π½Π΅ Π’Π 53 ΡΠ²Π»ΡΡΡΡΡ Π΄ΡΠ°ΠΉΠ²Π΅ΡΠΎΠΌ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°,Β ΡΠ»ΡΠΆΠ°Ρ Π½Π΅ ΡΠΎΠ»ΡΠΊΠΎ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠΌ Π°Π³ΡΠ΅ΡΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ, Π½ΠΎ ΠΈ Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΡΠΌ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΠΎΠΌ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡΒ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΊ Π»Π΅ΡΠ΅Π½ΠΈΡ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π½ΡΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ»ΡΡΠ°ΠΈ ΠΏΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡ, ΡΡΠΎ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡ ΡΠ³Π»ΡΠ±Π»Π΅Π½Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ²Β ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π’Π 53 ΠΏΡΠΈ ΠΎΠΏΡΡ
ΠΎΠ»ΡΡ
ΠΈ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΠΎΡΠ΅Π½ΠΊΠ° Π²ΡΠ΅Ρ
Π²ΡΡΠ²Π»ΡΠ΅ΠΌΡΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Π² ΠΈΠ½ΡΡΠΎΠ½Π°Ρ
Π³Π΅Π½Π° ΠΈ Ρ ΠΏΡΠΈΠ²Π»Π΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π°Π½Π°Π»ΠΈΠ·Π° in silico.Β
ΠΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Π½Π΅Ρ ΠΎΠ΄ΠΆΠΊΠΈΠ½ΡΠΊΠΈΠΌΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌΠΈ Π»ΠΈΠΌΡΠΎΠΌΠ°ΠΌΠΈ
.
ΠΠ°ΡΠΈΠ°Π½ΡΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΡΡ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π³Π΅Π½ΠΎΠ² Ρ53, XRCC1 ΠΈ XPD Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΎΡΡΡΡΠΌ Π»ΠΈΠΌΡΠΎΠ±Π»Π°ΡΡΠ½ΡΠΌ Π»Π΅ΠΉΠΊΠΎΠ·ΠΎΠΌ
.
Π‘Π²ΡΠ·Ρ ΠΌΠΈΠΊΡΠΎ-Π ΠΠ ΠΊΠ»Π°ΡΡΠ΅ΡΠ° miR-143/145 Ρ ΠΎΠ½ΠΊΠΎΠ³Π΅Π½Π΅Π·ΠΎΠΌ: ΡΠΊΠ°Π½Π΅Π²ΠΎΠΉ ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΉ ΠΊΠΎΠ½ΡΠ΅ΠΊΡΡ
The purpose of the study was to present up-to-date data on the regulation of expression, function in normal tissues and multidirectional activity in the oncogenesis of miR-143/145 microRNAs cluster, as well as to evaluate the possibilities and limitations of the therapeutic use of microRNAs of this cluster in malignant neoplasms. Material and methods. The search for available domestic and foreign literary sources published in PubMed and RSCI databases over the past 10 years has been carried out. 427 articles were found, of which 41 were included in this review. Results. The conservative cluster miR-143/145 is one of the most intensively studied in tumors. Based on the results of the analysis of differential miRNA expression, in vitro experiments in cancer cell lines and in vivo in mouse tumor models, a decrease in miR-143 and miR-145 levels was shown in malignant neoplasms of epithelial origin. Until recently, these miRNAs were considered classical oncosuppressors. The data presented in the review demonstrate that the results of a number of studies taking into account the cellular aspects of microRNA expression contradict this concept. miR-143 microRNA, for example, is known to participate in the metabolic restructuring of the tumor and the activation of neoangiogenesis. It has been shown that the oncosuppressive or pro-oncogenic activity of miR-143 and miR-145 depend on the tissue and cellular context and can be explained by the presence of several regulated targets that have opposite effects on oncogenesis. Taken together, the data obtained suggest the need to exercise caution when choosing the microRNAs of the described cluster for exogenous therapeutic delivery. Conclusion. Further detailed decoding of the mechanisms of miR-143 and miR-145 functioning in various types of tissues and cells, as well as identification of new MRNA targets are necessary for a better understanding of the involvement of these molecules in oncogenesis.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ - ΠΏΡΠ΅Π΄ΡΡΠ°Π²ΠΈΡΡ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ, ΡΡΠ½ΠΊΡΠΈΠΈ Π² Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΡ
ΡΠΊΠ°Π½ΡΡ
ΠΈ ΡΠ°Π·Π½ΠΎΠ½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π² ΠΎΠ½ΠΊΠΎΠ³Π΅Π½Π΅Π·Π΅ ΠΌΠΈΠΊΡΠΎΠ ΠΠ ΠΊΠ»Π°ΡΡΠ΅ΡΠ° miR-143/145, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎΡΠ΅Π½ΠΈΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΈ ΠΎΠ³ΡΠ°Π½ΠΈΡΠ΅Π½ΠΈΡ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΈΠΊΡΠΎΠ ΠΠ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΠΊΠ»Π°ΡΡΠ΅ΡΠ° ΠΏΡΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡΡ
. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ ΠΏΠΎΠΈΡΠΊ Π΄ΠΎΡΡΡΠΏΠ½ΡΡ
ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΈ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΡΡ
Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΡΡ
ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠΎΠ², ΠΎΠΏΡΠ±Π»ΠΈΠΊΠΎΠ²Π°Π½Π½ΡΡ
Π² Π±Π°Π·Π°Ρ
Π΄Π°Π½Π½ΡΡ
PubMed ΠΈ Π ΠΠΠ¦ Π·Π° ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΠ΅ 10 Π»Π΅Ρ. ΠΠ°ΠΉΠ΄Π΅Π½ΠΎ 427 ΡΡΠ°ΡΠ΅ΠΉ, ΠΈΠ· ΠΊΠΎΡΠΎΡΡΡ
41 Π±ΡΠ»Π° Π²ΠΊΠ»ΡΡΠ΅Π½Π° Π² Π΄Π°Π½Π½ΡΠΉ ΠΎΠ±Π·ΠΎΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎΠ½ΡΠ΅ΡΠ²Π°ΡΠΈΠ²Π½ΡΠΉ ΠΊΠ»Π°ΡΡΠ΅Ρ miR-143/145 ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎ ΠΈΠ·ΡΡΠ°Π΅ΠΌΡΡ
ΠΏΡΠΈ ΠΎΠΏΡΡ
ΠΎΠ»ΡΡ
. ΠΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π°Π½Π°Π»ΠΈΠ·Π° Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ ΠΌΠΈΠΊΡΠΎΠ ΠΠ, ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠΎΠ² in vitro Π² ΡΠ°ΠΊΠΎΠ²ΡΡ
ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
Π»ΠΈΠ½ΠΈΡΡ
ΠΈ in vivo Π² ΠΌΡΡΠΈΠ½ΡΡ
ΠΌΠΎΠ΄Π΅Π»ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ Π±ΡΠ»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ miR-143 ΠΈ miR-145 ΠΏΡΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡΡ
ΡΠΏΠΈΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠΈΡΡ
ΠΎΠΆΠ΄Π΅Π½ΠΈΡ. ΠΠΎ Π½Π΅Π΄Π°Π²Π½Π΅Π³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ Π΄Π°Π½Π½ΡΠ΅ ΠΌΠΈΠΊΡΠΎΠ ΠΠ ΡΡΠΈΡΠ°Π»ΠΈΡΡ ΠΊΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΎΠ½ΠΊΠΎΡΡΠΏΡΠ΅ΡΡΠΎΡΠ°ΠΌΠΈ. ΠΡΠΈΠ²Π΅Π΄Π΅Π½Π½ΡΠ΅ Π² ΠΎΠ±Π·ΠΎΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ Π΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΡΡΡ, ΡΡΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΡΠ΅Π»ΠΎΠ³ΠΎ ΡΡΠ΄Π° ΡΠ°Π±ΠΎΡ, ΡΡΠΈΡΡΠ²Π°ΡΡΠΈΡ
ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ ΠΌΠΈΠΊΡΠΎΠ ΠΠ, ΠΏΡΠΎΡΠΈΠ²ΠΎΡΠ΅ΡΠ°Ρ ΡΡΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅ΠΏΡΠΈΠΈ. ΠΠ»Ρ ΠΌΠΈΠΊΡΠΎΠ ΠΠ miR-143, Π½Π°ΠΏΡΠΈΠΌΠ΅Ρ, ΠΈΠ·Π²Π΅ΡΡΠ½ΠΎ ΡΡΠ°ΡΡΠΈΠ΅ Π² ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ΅ΡΠ΅ΡΡΡΠΎΠΉΠΊΠ΅ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΈ Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ Π½Π΅ΠΎΠ°Π½Π³ΠΈΠΎΠ³Π΅Π½Π΅Π·Π°. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΠΎΠ½ΠΊΠΎΡΡΠΏΡΠ΅ΡΡΠΎΡΠ½Π°Ρ ΠΈΠ»ΠΈ ΠΏΡΠΎΠΎΠ½ΠΊΠΎΠ³Π΅Π½Π½Π°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ miR-143 ΠΈ miR-145 Π·Π°Π²ΠΈΡΡΡ ΠΎΡ ΡΠΊΠ°Π½Π΅Π²ΠΎΠ³ΠΎ ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ½ΡΠ΅ΠΊΡΡΠ° ΠΈ ΠΌΠΎΠ³ΡΡ ΠΎΠ±ΡΡΡΠ½ΡΡΡΡΡ Π½Π°Π»ΠΈΡΠΈΠ΅ΠΌ Ρ Π½ΠΈΡ
Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΈΡ
ΡΠ΅Π³ΡΠ»ΠΈΡΡΠ΅ΠΌΡΡ
ΠΌΠΈΡΠ΅Π½Π΅ΠΉ, ΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡΠΈΡ
ΠΏΡΠΎΡΠΈΠ²ΠΎΠΏΠΎΠ»ΠΎΠΆΠ½ΡΠ΅ ΡΡΡΠ΅ΠΊΡΡ Π½Π° ΠΎΠ½ΠΊΠΎΠ³Π΅Π½Π΅Π·. Π ΡΠΎΠ²ΠΎΠΊΡΠΏΠ½ΠΎΡΡΠΈ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ Π³ΠΎΠ²ΠΎΡΡΡ ΠΎ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ ΠΏΡΠΎΡΠ²Π»ΡΡΡ ΠΎΡΡΠΎΡΠΎΠΆΠ½ΠΎΡΡΡ ΠΏΡΠΈ Π²ΡΠ±ΠΎΡΠ΅ ΠΌΠΈΠΊΡΠΎΠ ΠΠ ΠΎΠΏΠΈΡΡΠ²Π°Π΅ΠΌΠΎΠ³ΠΎ ΠΊΠ»Π°ΡΡΠ΅ΡΠ° Π΄Π»Ρ ΡΠΊΠ·ΠΎΠ³Π΅Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄ΠΎΡΡΠ°Π²ΠΊΠΈ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ°Π»ΡΠ½Π΅ΠΉΡΠ°Ρ Π΄Π΅ΡΠ°Π»ΡΠ½Π°Ρ ΡΠ°ΡΡΠΈΡΡΠΎΠ²ΠΊΠ° ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ miR-143 ΠΈ miR-145 Π² ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΠΈΠΏΠ°Ρ
ΡΠΊΠ°Π½Π΅ΠΉ ΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π½ΠΎΠ²ΡΡ
ΠΌΠ ΠΠ-ΠΌΠΈΡΠ΅Π½Π΅ΠΉ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡ Π΄Π»Ρ Π»ΡΡΡΠ΅Π³ΠΎ ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΡ ΡΡΠ°ΡΡΠΈΡ Π΄Π°Π½Π½ΡΡ
ΠΌΠΎΠ»Π΅ΠΊΡΠ» Π² ΠΎΠ½ΠΊΠΎΠ³Π΅Π½Π΅Π·Π΅
- β¦